LiFraumeni syndrome (LFS) is a rare, inherited disorder which leads to a higher risk of developing certain cancers. These cancers tend to occur at younger ages in individuals with LFS than inLFS as a Disease. LFS: Another name for LiFraumeni syndrome (or close medical condition association). Introduction: LiFraumeni syndrome Symptoms of LiFraumeni syndrome. LFS: Related Diseases. LFS: LFS is listed as a type of (or associated with) the following medical conditions in our database: Genetic conditions; Benign tumors; Soft tissue tumors; Cancer lfs disease
LiFraumeni syndrome is a rare disorder that greatly increases the risk of developing several types of cancer, particularly in children and young adults. The cancers most often associated with LiFraumeni syndrome include breast cancer, a form of bone cancer called osteosarcoma, and cancers of soft tissues (such as muscle) called soft tissue sarcomas.
LiFraumeni syndrome (LFS) is a rare hereditary condition that increases a person's risk for a wide spectrum of tumors. In LFS, the tendency to develop cancer is inherited, meaning that it can be passed from an affected parent to a child. LFS is the primary link between the health of California citizens and quality oriented, accurate and reliable clinical laboratory testing. LFS provides oversight for clinical and public health laboratory operations and for the licensed and certified scientists and other testing personnel wholfs disease The classical LFS malignancies sarcoma, cancers of the breast, brain and adrenal glands comprise about 80 of all cancers that occur in this syndrome. The risk of developing any invasive cancer (excluding skin cancer) is 50 by age 30 (1 in the general population) and is 90 by age 70.